SeqOne Genomics offers a cloud-based solution that manages the entire genomic analysis process from raw data to final report presented to clinicians, leveraging advanced machine learning and its proprietary GeniOS™ genomics operating system. The company is investing in a genomic-aware data lake to improve the use of big data and machine-learning approaches in genomic analysis. It develops collaborative genomic analysis tools to facilitate communication between different disciplines in the medical team and aims to improve patient outcomes in cancer and hereditary disease. SeqOne’s solution has been adopted by a score of hospitals, central labs and biopharmas and has spawned partnerships with leading manufacturers of genomics analysis hardware and reagents. The company currently employs over 40 staff and plans to double its headcount within the year to execute its growth plans. Since founding, SeqOne has positioned itself to reduce turnaround times and costs while delivering actionable insights for personalized medicine.

Total raised

$23M

Funding rounds

1

Latest round

Series A

Latest activity

Jan 2022